<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T02:20:49Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/4633" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/4633</identifier><datestamp>2025-10-24T10:22:30Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes</dc:title>
   <dc:creator>Gil Moreno, Antonio</dc:creator>
   <dc:creator>Carbonell Socias, Melchor</dc:creator>
   <dc:creator>Salicrú Riera, Sabina</dc:creator>
   <dc:creator>Bradbury Lobato, Melissa</dc:creator>
   <dc:creator>García Jiménez, Angel</dc:creator>
   <dc:creator>Vergés Capdevila, Ramona</dc:creator>
   <dc:creator>Puig Puig, Oriol</dc:creator>
   <dc:creator>Sánchez Iglesias, José Luis</dc:creator>
   <dc:creator>Cabrera Diaz, Silvia</dc:creator>
   <dc:creator>De la Torre Fdez de Vega, Fco Javier</dc:creator>
   <dc:creator>Perez Benavente, Maria Asuncion</dc:creator>
   <dc:creator>Rodriguez Gómez-Hidalgo, Natalia</dc:creator>
   <dc:creator>Díaz-Feijoo, Berta</dc:creator>
   <dc:contributor>[Gil-Moreno A, Carbonell-Socias M, Salicrú S, Bradbury M, Puig OP, Sánchez-Iglesias JL, Cabrera-Díaz S, de-la-Torre J, Gómez-Hidalgo NR, Pérez-Benavente A, Díaz-Feijoo B] Unitat de Ginecologia Oncològica, Servei d’Obstetrícia i Ginecologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [García Á] Servei de Patologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Vergés R] Servei de Radioteràpia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain.</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Histerectomia</dc:subject>
   <dc:subject>Coll uterí - Càncer</dc:subject>
   <dc:subject>Anàlisi de supervivència (Biometria)</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Urogenital Surgical Procedures::Gynecologic Surgical Procedures::Hysterectomy</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Uterine Cervical Neoplasms</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos quirúrgicos urogenitales::procedimientos quirúrgicos ginecológicos::histerectomía</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias del cuello uterino</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::estadística como asunto::análisis de supervivencia</dc:subject>
   <dc:description>Cervical cancer; Surgical treatment; Morbidity</dc:description>
   <dc:description>Càncer cervical; Tractament quirúrgic; Morbilidad</dc:description>
   <dc:description>Càncer cervical; Tractament quirúrgic; Morbiditat</dc:description>
   <dc:description>OBJECTIVES:&#xd;
There are controversies regarding the long-term oncological safety of preservation of pelvic innervation during radical hysterectomy (RH). This study aimed to analyze the feasibility and safety of nerve-sparing radical hysterectomy (NSRH) for cervical cancer compared with non-NSRH following 17 years of experience in a tertiary cancer referral center.&#xd;
&#xd;
MATERIALS AND METHODS:&#xd;
Between May 1999 and June 2016, all patients who underwent RH for cervical cancer were followed-up prospectively. Comparison analyses regarding surgical outcomes, complications, overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS) were performed between patients treated with NSRH and non-NSRH.&#xd;
&#xd;
RESULTS:&#xd;
A total of 188 patients were included (113 non-NSRH and 75 NSRH). The median follow-up was 112 months. Estimated blood loss and hospital stay were all significantly lower in the NSRH group. Overall intraoperative complication rate (p = 0.02) and need for transfusion (p = 0.016) were lower in the NSRH group. There were no differences in the median operation time, OS, DFS, CSS, or recurrence rates between the NSRH and non-NSRH group.&#xd;
&#xd;
CONCLUSIONS:&#xd;
Our study provides a wide perspective on the developments of nerve-sparing procedures for the management of women with early-stage cervical cancer. Our results suggest that NSRH is a feasible and safe procedure, with reduced morbidity outcomes.</dc:description>
   <dc:date>2020-02-14T12:41:57Z</dc:date>
   <dc:date>2020-02-14T12:41:57Z</dc:date>
   <dc:date>2019-07-16</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Gil-Moreno A, Carbonell-Socias M, Salicrú S, Bradbury M, García A, Vergés R, et al. Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes. Oncotarget. 2019 Jul 16;10(44):4598–608.</dc:identifier>
   <dc:identifier>1949-2553</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/4633</dc:identifier>
   <dc:identifier>10.18632/oncotarget.27078</dc:identifier>
   <dc:identifier>31360307</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/4633</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Oncotarget;10(44)</dc:relation>
   <dc:relation>http://www.oncotarget.com/index.php?journal=oncotarget&amp;page=article&amp;op=view&amp;path[]=27078&amp;path[]=86082</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Impact Journals</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>